Table 1.
Genes exhibiting Tag-SNPs associated with the risk of developing AD and age at onsert following the systematic genetic analysis of 1,156 SNPs by microarray experiments.
GENE | RefSeq | Chr. | Chromosomal locationa | Differential expressionb | Number of studied SNPs | Number of associated SNPsc | Association with age at onsetc |
---|---|---|---|---|---|---|---|
MYO10 | NM_012334 | 5 | 16,715,016–16,989,385 | + 201% | 103 | 24 | 4 |
ITGA2 | NM_002203 | 5 | 52,320,913–52,426,365 | + 215% | 26 | 3 | |
LOC221608 | NM_007047 | 6 | 26,473,377–26,486,525 | − 45% | 13 | 2 | |
TNXB | NM_019105 | 6 | 32,116,911–32,185,131 | + 100% | 31 | 4 | |
AGER | NM_001136 | 6 | 32,256,724–32,260,001 | − 53% | 7 | 4 | |
HLA-DRA | NM_019111 | 6 | 32,515,625–32,520,799 | − 57% | 10 | 5 | |
PHF1 | NM_002636 | 6 | 33,486,934–33,492,187 | − 47% | 4 | 3 | |
CCDN3 | NM_001760 | 6 | 42,010,650–42,017,530 | + 157% | 9 | 3 | |
IL-33 | NM_033439 | 9 | 6,231,678–6,247,982 | − 66% | 4 | 2 | |
FLJ20375 | AK000382 | 9 | 20,939,639–20,985,947 | − 62% | 55 | 9 | |
B4GALT1 | NM_001497 | 9 | 33,100,642–33,157,231 | − 43 % | 9 | 5 | |
CNTFR | NM_001842 | 9 | 34,541,431–34,579,722 | +132 % | 16 | 7 | 2 |
CA9 | NM_001216 | 9 | 35,663,915–35,671,152 | −50% | 11 | 1 | |
KIAA1462 | NM_020848 | 10 | 30,343,390–30,376,806 | + 262% | 18 | 3 | 5 |
CAMK2G | NM_001222 | 10 | 75,242,265–75,304,344 | −50% | 10 | 7 | |
ANGPT4 | NM_009641 | 20 | 801,604–844,605 | − 65% | 42 | 6 | 5 |
HSPA12B | NM_175842 | 20 | 4,103,675–4,116,352 | − 42% | 15 | 2 |
Assembly Mar. 2006 (http://genome.ucsc.edu/cgi-bin/hgGateway)
differential expression between brain of AD cases and controls
nominal P-value < 0.05